WaisMed
Device for Rapid Intravascular Access
Company Overview
Snapshot
Founded in February 1994, WaisMed operated with 1–10 employees, developing medical devices for emergency and critical care. The company was acquired by PerSys Medical in December 2004.
Business overview
WaisMed specializes in the development and manufacturing of medical devices for emergency and critical care applications within the Health Tech & Life Sciences sector. The company's core technology includes an automatic, mechanical, disposable device for rapid intraosseous (IO) access into the vascular system, exemplified by its Bone Injection Gun and NIO devices. These products provide rapid, safe, and easy intravascular access through bone marrow, serving markets such as hospitals, veterinary care, and military first aid, primarily in the United States and Canada.
Log in to access full profile ›Company Intelligence Q&A
- When was WaisMed acquired?
- WaisMed was acquired by PerSys Medical in December 2004.
- What is WaisMed's primary product?
- WaisMed's primary product is the Bone Injection Gun (B.I.G), an automatic, mechanical, disposable device for rapid intraosseous access into the vascular system.
- What regulatory approvals has WaisMed received for its NIO device?
- In October 2014, WaisMed received FDA approval and a CE mark for its NIO, a new intraosseous medical device.
- What is the primary sector of WaisMed?
- WaisMed operates within the Health Tech & Life Sciences sector, focusing on medical devices.
- What is the purpose of WaisMed's intraosseous devices?
- WaisMed's intraosseous devices provide rapid, safe, and easy intravascular access through the bone marrow for administering fluids, medications, and blood products in emergency and critical care settings.